Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01724307 · ClinicalTrials.gov registry record · NA

Stimulation of the Cervical Sympathetic Ganglion for Treatment of Asthma

A NA study of Asthma, sponsored by Jonathan Parsons.

Completed
Registry status
NA
Development phase
1
Enrollment target
1
Study location

NCT01724307: Completed NA study of Asthma, sponsored by Jonathan Parsons.

NCT01724307 is a NA study of Asthma that has completed, run by Jonathan Parsons. The registered enrollment target is 1 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01724307, a NA study of Asthma, has completed, sponsored by Jonathan Parsons.

COMPLETED
Registry status
NA
Development phase
1 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate if stimulating the nerve involved with airway constriction, while undergoing procedures that are known to cause asthma exacerbations, decreases the level of asthma attack experienced.

Conditions Studied

Interventions

  • PROCEDURE Neurostimulation of stellate ganglion

Study Locations (1)

Ohio

  • The Ohio State University - Columbus

Trial Details

FieldValue
Enrollment Target 1 participants
Start Date 2011-09
Est. Completion 2013-11
Phase NA

Sponsor

Jonathan Parsons

1 total trials

What the Registry Record Tells You About NCT01724307

The ClinicalTrials.gov registry entry for NCT01724307 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (100% lower). The listed sponsor is Jonathan Parsons, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 1 intervention - of which Neurostimulation of stellate ganglion is the first listed.

NCT01724307 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT01724307 about?

NCT01724307 is a clinical study titled "Stimulation of the Cervical Sympathetic Ganglion for Treatment of Asthma". The purpose of this study is to evaluate if stimulating the nerve involved with airway constriction, while undergoing procedures that are known to cause asthma exacerbations, decreases the level of asthma attack experienced.

What is the current status of trial NCT01724307?

This trial is currently completed. It is a NA study. The enrollment target is 1 participants. The study started on 2011-09. Estimated completion is 2013-11.

What conditions does trial NCT01724307 study?

This clinical trial studies the following conditions: Asthma.

What interventions are being tested in trial NCT01724307?

The interventions under investigation include: Neurostimulation of stellate ganglion (PROCEDURE).

Who is sponsoring clinical trial NCT01724307?

This trial is sponsored by Jonathan Parsons, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01724307 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Asthma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.